Literature DB >> 34267871

Novel Substituted 3,4-Dihydroquinazoline Derivatives for Treating Hepatitis B Virus Infection.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34267871      PMCID： PMC8274074          DOI： 10.1021/acsmedchemlett.1c00296

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Can we cure hepatitis B virus with novel direct-acting antivirals?

Authors:  Maria G Martinez; François Villeret; Barbara Testoni; Fabien Zoulim
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 2.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

Review 3.  Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression.

Authors:  Zhenyu Liao; Wang Jiang; Longyun Ye; Tianjiao Li; Xianjun Yu; Liang Liu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-07-28       Impact factor: 10.680

Review 4.  Hepatitis B virus biology and life cycle.

Authors:  Senko Tsukuda; Koichi Watashi
Journal:  Antiviral Res       Date:  2020-08-28       Impact factor: 5.970

Review 5.  Hepatitis B virus-host interactions and novel targets for viral cure.

Authors:  Gaëtan Ligat; Eloi R Verrier; Michael Nassal; Thomas F Baumert
Journal:  Curr Opin Virol       Date:  2021-05-22       Impact factor: 7.121
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.